Cite
HARVARD Citation
Gilleen, J. et al. (2021). The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial. Journal of psychopharmacology. pp. 15-22. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gilleen, J. et al. (2021). The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial. Journal of psychopharmacology. pp. 15-22. [Online].